Vitamin B3 and Glioblastoma: High-Dose Niacin Trial
Quick Facts
Could Vitamin B3 Help Treat Glioblastoma?
Glioblastoma is classified by the World Health Organization as a highly malignant central nervous system tumor, and standard care typically combines maximal safe surgery, radiation therapy, and temozolomide chemotherapy. Survival has improved since the landmark temozolomide radiotherapy regimen was established, but long-term control remains difficult for many patients.
The new interest in vitamin B3 centers on niacin at pharmacologic doses, not ordinary multivitamin intake. Early laboratory and translational research suggests niacin may influence immune-cell metabolism and inflammatory signaling, which are important because glioblastoma can suppress local immune responses inside the brain tumor environment.
Why Would Niacin Affect Brain Cancer Immunity?
Vitamin B3 is a precursor for nicotinamide adenine dinucleotide, or NAD, a molecule involved in cellular energy metabolism and DNA repair. Cancer researchers are interested in NAD-related pathways because rapidly dividing tumor cells and immune cells both depend on metabolic signals to function.
In glioblastoma, one major challenge is that immune cells entering the tumor may become exhausted or functionally suppressed. A therapy that safely restores useful immune activity could, in theory, make existing treatments more effective, but that hypothesis must be tested in controlled human trials before it changes clinical care.
Should Patients Take High-Dose Vitamin B3 Now?
Dietary vitamin B3 is essential, but high-dose niacin behaves more like a drug than a nutrient. It can cause flushing, itching, gastrointestinal symptoms, liver toxicity, changes in blood sugar, and interactions with other medicines, especially when used at doses far above nutritional requirements.
For patients with glioblastoma, the safest path is to ask the treating neuro-oncology team about clinical trial eligibility. Trial protocols can monitor dosing, side effects, imaging results, steroid use, seizure medicines, and interactions with radiation or chemotherapy in a structured way.
Frequently Asked Questions
No. Vitamin B3 is being investigated as an experimental strategy, but there is no evidence that niacin cures glioblastoma or replaces surgery, radiation, chemotherapy, or tumor-treating fields.
No. The research interest involves medically supervised high-dose niacin, which is different from standard dietary intake or a routine multivitamin.
Patients can ask whether any glioblastoma clinical trials are appropriate for their tumor type, treatment stage, performance status, medications, and molecular markers such as MGMT promoter methylation or IDH status.
References
- ScienceDaily. A common vitamin could help fight one of the deadliest brain cancers. June 2026.
- Stupp R, Mason WP, van den Bent MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. New England Journal of Medicine. 2005.
- National Cancer Institute. Glioblastoma Treatment (PDQ) - Health Professional Version.
- World Health Organization Classification of Tumours Editorial Board. Central Nervous System Tumours. WHO Classification of Tumours, 5th Edition. 2021.